Posted on 05/03/2023 11:12:58 AM PDT by nickcarraway
Pfizer’s latest quarterly results underscored the pressure the drugmaker is facing to sustain sales growth by hitting on drugs in development and recent acquisitions as demand wanes for its leading Covid-19 products.
Pfizer’s first-quarter revenue and earnings were down by nearly a third from a year ago on plummeting demand for its Covid-19 vaccine, though the results topped Wall Street expectations.
The company also faces sales declines for big-selling products in coming years due to expected patent expirations that will clear the way for lower-cost competition. Pfizer could lose $17 billion in sales from these patent losses.
(Excerpt) Read more at msn.com ...
Awwww. I hope they can pull through.
Wuhan? This is Pfizer....start cranking out another one stat!
Pfizer’s vets and fake docs have murdered
their customers, their families and sterilized
their children.
They deserve a short trial for the murders and genocide.
My heart grieves for poor Pfizer/s
Funeral Home biz is booming hoever.
Time for more government mandates to buy their products.
Wait until the lawsuits start. It’s going to to get worse.
What lawsuits?
The Texas AG is suing Pfizer for fraud. It is the first of many.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.